Corrigendum Efficacy of transarterial chemoembolization‑hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis | Synapse
March 3, 2026Open Access
Corrigendum Efficacy of transarterial chemoembolization‑hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis
Puntos clave
The correction addresses findings on treatment efficacy for liver cancer with portal vein thrombosis.
Reported therapy efficacy includes transarterial chemoembolization and immunotherapy among other methods.
The observational analysis corrects previously reported efficacy metrics based on combined treatment approaches.
Future studies are needed to validate these findings and assess broader clinical implications.
Resumen
This corrects the article DOI: 10.3892/ol.2025.15109..